openPR Logo
Press release

Global Anti-Obesity Drugs Market Research 2017 Top Players : Pfizer, Merck, Norgine

11-09-2017 02:13 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: QYresearchreports

QYresearchreports

QYresearchreports

Qyresearchreports include new market research report "Global Anti-Obesity Drugs Market Research Report 2017" to its huge collection of research reports.

The report on the global market for Anti-Obesity Drugs tries to help stakeholders gather a proper understanding about the current trends and vulnerabilities of the market. It is made up of important information that provide a thorough insight into the global market for Anti-Obesity Drugs. This is comprised of growth drivers and restraints shaping the trajectory of the market from 2017 to 2022. The report also sheds light on the different regulatory policies likely to mold the course of the market in the next couple of years.

The information has been packed in the report after complete primary and secondary research. Data related to financial records of key companies in the market has been obtained from the Anti-Obesity Drugs market’s historical statistics. Further, analysts have also interviewed industry veterans and other trusted industry sources for necessary insights needed to compile the detailed report.

The report banks upon market-leading analytical tools such as Porter’s five forces and SWOT analysis to gain an accurate understanding of the bargaining power of buyers and suppliers and the threat from new entrants and close substitutes available in the market. It also helps to figure out the opportunities and pitfalls awaiting players in the global Anti-Obesity Drugs market.

Have Any Query? Ask Our Expert @ https://www.qyresearchreports.com/sample/sample.php?rep_id=925006&type=S

This report studies Anti-Obesity Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
Pfizer
Merck
F.Hoffmann-La Roche
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Novo Nordisk
Eisai
Norgine
Arena Pharmaceuticals
Orexigen Therapeutics

To further scrutinize the global market for Anti-Obesity Drugs, the report segments it based on various parameters such as type of products and applications and geography. It also attempts to uncover the most attractive segments and regions that are considerably contributing to the growth in the market.

The report provides an executive-level blueprint of the global Anti-Obesity Drugs market that comprises of profiles of the prominent companies operating in it. It studies their unique selling points (USPs) and weaknesses and key strategies as well.

Table of Contents

1 Anti-Obesity Drugs Market Overview
1.1 Product Overview and Scope of Anti-Obesity Drugs
1.2 Anti-Obesity Drugs Segment by Type
1.3 Anti-Obesity Drugs Segment by Application
1.4 Anti-Obesity Drugs Market by Region
1.5 Global Market Size (Value) of Anti-Obesity Drugs (2012-2022)

2 Global Anti-Obesity Drugs Market Competition by Manufacturers
2.1 Global Anti-Obesity Drugs Production and Share by Manufacturers (2015 and 2016)
2.2 Global Anti-Obesity Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Anti-Obesity Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Anti-Obesity Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Anti-Obesity Drugs Market Competitive Situation and Trends

Get more information from Table of Content: https://www.qyresearchreports.com/report/global-anti-obesity-drugs-market-research-report-2017.htm/toc

7 Global Anti-Obesity Drugs Manufacturers Profiles/Analysis

7.1 Pfizer
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Anti-Obesity Drugs Product Type, Application and Specification
7.1.2.1 Prescription Drugs
7.1.2.2 OTC Drugs
7.1.3 Pfizer Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview

7.2 Merck
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Anti-Obesity Drugs Product Type, Application and Specification
7.2.2.1 Prescription Drugs
7.2.2.2 OTC Drugs
7.2.3 Merck Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview

List of Tables and Figures

Figure Picture of Anti-Obesity Drugs
Figure Global Production Market Share of Anti-Obesity Drugs by Type in 2015
Table Anti-Obesity Drugs Consumption Market Share by Application in 2015
Figure Global Anti-Obesity Drugs Revenue (Million UDS) and Growth Rate (2012-2022)
Table Global Anti-Obesity Drugs Production of Key Manufacturers (2015 and 2016)
Table Global Anti-Obesity Drugs Production Share by Manufacturers (2015 and 2016)
Table Global Anti-Obesity Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Anti-Obesity Drugs Revenue Share by Manufacturers (2015 and 2016)

About Us

QYReseachReports.com delivers the latest strategic market intelligence to build a successful business footprint in China. Our syndicated and customized research reports provide companies with vital background information of the market and in-depth analysis on the Chinese trade and investment framework, which directly affects their business operations. Reports from QYReseachReports.com feature valuable recommendations on how to navigate in the extremely unpredictable yet highly attractive Chinese market.

Contact US:

1820 Avenue
M Suite #1047
Brooklyn, NY 11230
United States
Toll Free: 866-997-4948 (USA-CANADA)
Tel: +1-518-621-2074
Email: sales@qyresearchreports.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Anti-Obesity Drugs Market Research 2017 Top Players : Pfizer, Merck, Norgine here

News-ID: 809833 • Views: 132

More Releases from QYresearchreports

Global Oilfield Communication Equipment Market Latest Achievements and Opportuni …
Qyresearchreports include new market research report Global Oilfield Communication Equipment Market Insights, Forecast to 2025 to its huge collection of research reports. The Oilfield Communication Equipment market was valued at Million US$ in 2018 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to
Global Power Over Ethernet (POE) Lighting Market : Key Growth Factors and Foreca …
Qyresearchreports include new market research report Global Power Over Ethernet (POE) Lighting Market Insights, Forecast to 2025 to its huge collection of research reports. This report presents the worldwide Power Over Ethernet (POE) Lighting market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities
Global Automatic Palletizer and Depalletizer Market to be at Forefront by 2025 | …
Qyresearchreports include new market research report Global Automatic Palletizer and Depalletizer Market Insights, Forecast to 2025 to its huge collection of research reports. Automatic palletizer and depalletizer is a machine that enables automatic stacking of goods and products. It also enables the depalletizing or unloading of goods. The rising consumer income and European Central Bank (ECB) bond-buying program will influence the buying pattern of consumers in EMEA and will result in
Global Weather Forecasting Equipment Market Advancement Analysis and Precise Out …
Qyresearchreports include new market research report Global Weather Forecasting Equipment Market Insights, Forecast to 2025 to its huge collection of research reports. The Weather Forecasting Equipment market was valued at Million US$ in 2018 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to

All 5 Releases


More Releases for Drugs

Global Cardiovascular Drugs Market
Global Cardiovascular Drugs Market – Industry Analysis and Forecast (2018-2026) – by Drug Class, Indications, Distribution Channels, and Region. Global Cardiovascular Drugs Market was valued at US$ 80.5 Bn in 2017 and is expected to reach US$ 98.8 Bn by 2026, at a CAGR of 2.6 % during the forecast period. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data,
Cardiovascular Drugs Market | Insights
Some of the common cardiovascular diseases include hypertensive heart disease, rheumatic heart disease, ischemic heart disease, inflammatory heart disease, and cerebrovascular heart disease. Major problems associated with hypertensive heart disease include angina, hypertrophy, and heart failure. These problems are caused due to high blood pressure in the heart’s arteries and muscles, which causes narrowing of arteries and thickening and enlargement of heart. The global cardiovascular drug market is primarily driven
Immunotherapy Drugs Market
Immunotherapy drugs are used to treat cancer, infection, respiratory and autoimmune disorders. Immunotherapies either stimulate the activities done by specific components of the immune system or counteract the signals that are produced by the cancer cells and suppress the immune responses. The Immunotherapy Drugs Market accounted to USD 107 billion in 2016 growing at a CAGR of 13.2% during the forecast period of 2017 to 2024. The upcoming market report contains
Immunotherapy Drugs Market
Immunotherapy is the management of a disease by enhancing, suppressing, or inducing an immune response. Some immunotherapies are designed to magnify or elicit an immune response. They are known as activation immunotherapies. However, some immunotherapies that suppress or reduce the immune response are known as suppression immunotherapies. Cell-based immunotherapies are useful for some types of cancers. Immune effector cells includingmacrophages, dendritic cells, lymphocytes, cytotoxic T lymphocytes (CTL), natural killer cells
Tardive Dyskinesia Drugs Market
Tardive dyskinesia (TD) is a form of dyskinesia that is difficult to treat. It is a nerve disorder characterized by involuntary movements such as jaw, lips, and tongue, considered as grimacing, sticking the tongue out, and lip smacking. Some other symptoms are an individual experiencing involuntary movement of the lower and upper extremities and also breathing choking. According to Center for Drug Evaluation and Research, tardive dyskinesia can lead to
Erythropoietin Drugs Market
Erythropoietin alfa is widely used to treat anemia and increase the red blood cells count in the body. Erythropoietin drugs are developed in vitro by extracting the erythropoietin from the human body and developing it through the use of recombinant DNA technology. Erythropoietin drugs are also used to treat anemia induced from cancer, multiple myloma and HIV associated anemia. Recombinant DNA technology has allowed researchers to develop synthetic forms of